7 unknown. 7 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Unknown 7 |
| Phase 2 | 3 | Unknown 3 |
Follow Pulmonary Fibrosis: new trials by email Literature Review of Pulmonary Fibrosis trials Research Report on Pulmonary Fibrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess Efficacy and Safety of Treamid for Patients With Reduced Exercise Tolerance After COVID-19 Treamid, Treamid twice a day, Treamid once a day - SARS-CoV-2 Infection, Lung Fibrosis | Phase 2 / Phase 3 | Unknown | PHARMENTERPRISES LLC | 412 | 2022-08-01 | 2022-08-25 |
| Morphine for Dyspnea in Pulmonary Fibrosis Morphine hydrochloride, Placebo - Idiopathic Pulmonary Fibrosis (IPF) | Phase 3 | Unknown | Medical University of Gdansk | 20 | 2020-09-21 | 2020-08-04 |
| Pirfenidone in the Chronic Hypersensitivity Pneumonitis Treatment Placebo, Pirfenidone - Alveolitis Extrinsic Allergic, Pulmonary Fibrosis | Phase 2 / Phase 3 | Unknown | Grupo Medifarma, S. A. de C. V. | 60 | 2015-07-01 | 2015-07-14 |
| Furosemide Stress Test as a Predictor of Tubular Function in Chronic Kidney Disease Furosemide - Chronic Kidney Disease | Phase 3 | Unknown | Instituto Nacional de Cardiologia Ignacio Chavez | 100 | 2015-04-01 | 2015-04-16 |
| Trial of Concurrent Versus Sequential Tamoxifen With Radiotherapy in Breast Cancer Patients Tamoxifen, Radiotherapy - Pulmonary Fibrosis, Breast Cancer | Phase 3 | Unknown | Tata Memorial Hospital | 260 | 2008-12-01 | 2011-08-30 |
| Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis Iloprost inhalation - Pulmonary Fibrosis, Pulmonary Hypertension | Phase 2 / Phase 3 | Unknown | Interstitial Lung Disease Study Group, Korea | 15 | 2007-03-01 | 2007-02-23 |
| Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot Study minocycline - Idiopathic Pulmonary Fibrosis | Phase 3 | Unknown | University of California, Los Angeles | 2006-09-11 |
Idiopathic Pulmonary Fibrosis (2) · Alveolitis, Extrinsic Allergic (1) · Breast Neoplasms (1) · COVID-19 (1) · Hypertension, Pulmonary (1) · Renal Insufficiency, Chronic (1)
Lung Diseases (7) · Lung Diseases, Interstitial (7) · Respiratory Tract Diseases (7) · Fibrosis (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Breast Diseases (1) · Cardiovascular Diseases (1) · Chronic Disease (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1)
Excipients (1) · Furosemide (1) · Minocycline (1) · N,N'-bis(2-(1H-imidazol-2-yl)ethyl)pentanediamide (1) · Radiotherapy (1) · Tamoxifen (1) · pirfenidone (1)
Grupo Medifarma, S. A. de C. V. (1) · Instituto Nacional de Cardiologia Ignacio Chavez (1) · Interstitial Lung Disease Study Group, Korea (1) · Medical University of Gdansk (1) · PHARMENTERPRISES LLC (1) · Tata Memorial Hospital (1) · University of California, Los Angeles (1)
Mexico (2) · India (1) · South Korea (1) · United States (1)
Anusheel Munshi, MD (1) · Dong Soon Kim, MD (1) · Eric Kleerup, MD (1) · Magdalena Madero, MD (1)
PMID 24053972, PMID 31784348, PMID 32143585
2019 (1)